Review our comprehensive list of published human cancer T-cell epitopes.
Get Early Access to MR1 Products for MAIT Cell Research. Learn More.
Harnessing the Immune System in the Fight Against Cancer
Immunity-Informed Decisions about Cancer Treatments
Guided to recognize cancer cells, the human cellular immune response has the power to mount a fast and fierce attack on tumors. A key aspect of immunotherapeutic strategies is the detailed monitoring of cancer-specific T-cell populations in patients to detect existing or induced immunity, understand immune escape, and track patient response to treatments.
Immudex has specific reagents as well as predefined Dextramer® panels to detect, quantify and isolate these cell populations. Alternatively, design Dextramer® reagents to match your cancer immune monitoring.


New Therapies from Unraveled Immune Complexity
Reactions of the immune system to the presence of cancer cells are complex and varied. A diversity of immune cells interact in a collective response, each with different receptor affinities to specific tumor antigens. Elucidating that complexity can reveal new modes of action for potential therapies.
Dextramer® reagents detect and characterize the complete spectrum of cells involved in the cellular immune response, including low-affinity CD8+ and CD4+ T cells.
T cells
T cells that have infiltrated a tumor (TILs) can be isolated, activated, expanded, and reinfused into the patient to mount a strong attack on the tumor. The same cells may also be equipped with a new receptor (TCR) to target specific cancer antigents.
Monitor cancer-specific CD8+ T cells
CAR-T cells
T cells engineered with cancer-targeting chimeric antigen receptors (CARs), with the ability to target a specific protein. They are designed to recognize highly specific antigens and either kill tumor cells or modulate immune responses.
NKT cells
Activated natural killer T (NKT) cells fight cancer directly in an antigen-specific cytotoxic attack. They can also activate other immune cells. The activity of these unique cells is CD1d-dependent, opening the opportunity to detect them in samples.
B cells
B cells produce antibodies and act as potent antigen-presenting cells to induce antitumor-specific T-cell responses. With well-defined epitopes and sensitive reagents, diverse B-cell populations can be stratified and their role in immunity revealed.
Mouse Cancer Epitopes
Discover the comprehensive list of murine models and cancer T-cell epitopes.
Case Studies
Discover the impact of Dextramer® technology in case studies in the field of cancer research
Publications
Learn about the uses, experiences, and finding in cancer research in our list of publications.